Omeros | OMER - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Adma Biologics USD 232.29M 5.59M 2026-03
Alnylam Pharmaceuticals USD 133.73M 290K 2026-06
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Cytokinetics USD 124.43M 2.17M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
Heron Therapeutics USD 188.31M 4.99M 2025-12
Immunic USD 120.38M 21.73M 2025-12
Insmed USD 218.28M 1.76M 2026-06
Knight Therapeutics CAD 99.68M 24.66K 2025-09
MacroGenics USD 63.56M 241K 2026-03
Omeros USD 611K 17K 2023-12
Pacira USD 39.82M 512K 2026-06
Pfizer USD 5.7B 0 2026-06
Sarepta Therapeutics USD 105.62M 53K 2026-06
United Therapeutics USD 42.68M 521K 2026-06
Vertex Pharmaceuticals USD 253.3M 900K 2026-06